New rules on transparency: detailed arrangements for stakeholders

Written by Embio Diagnostics

January 11, 2021

The new regulation aimed at increasing the transparency of risk assessment in the food chain becomes applicable on 27 March 2021. As part of the implementation process, EFSA has published detailed arrangements for how the new rules and measures specified in the regulation will operate in practice. The arrangements are aimed primarily at EFSA’s stakeholders, such as applicants who want to place food products on the EU market.

The “practical arrangements” (PAs) for implementing the regulation will help stakeholders to better understand how the new processes and tools affect them and what adjustments they need to make to operate effectively in the new environment. They were drafted following extensive consultation with stakeholders, the European Commission and EU Member States throughout 2020.

The PAs cover areas such as proactive transparency, confidentiality, notification of studies, pre-submission advice and consultation of third parties. EFSA has already published PAs on the processing of applications for access to documents held by EFSA.

To further support stakeholders preparing for the new arrangements, over the next weeks and months EFSA will be producing a range of supporting materials such as animated tutorials and holding a series of training sessions. A calendar of planned activities can be found on the EFSA website.

Background

The aim of the new regulation is to increase the transparency of risk assessment in the food chain, strengthen the reliability, objectivity and independence of the scientific studies submitted to EFSA and reinforce the governance of EFSA to ensure the Authority’s long-term sustainability. It was developed in response to a European Citizens’ Initiative on pesticides and the findings of the review of the General Food Law Regulation that was completed in January 2018.

You can find out more on the European Commission website.

https://www.efsa.europa.eu/en/news/new-rules-transparency-detailed-arrangements-stakeholders

You May Also Like…

About Us.

EMBIO Diagnostics (EMBIO) designs and develops custom based hardware solutions and consults as an expert in the biotechnology at a global scale.

Follow the developments.

 

Contact us

Get In Touch

Cyprus

(+357) 22515175
info@embiodiagnostics.eu
M-F: 9am-6pm

Athalassas Avenue 8B,2018, NIcosia

USA

(+001) 973 876 1792

sales@embiodiagnostics.eu